174 related articles for article (PubMed ID: 33425743)
1. Analysis of Prognostic Factors of World Health Organization Grade Ⅲ Meningiomas.
Tian W; Liu J; Zhao K; Wang J; Jiang W; Shu K; Lei T
Front Oncol; 2020; 10():593073. PubMed ID: 33425743
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
3. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
4. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
5. WHO grade II and III meningiomas: a study of prognostic factors.
Durand A; Labrousse F; Jouvet A; Bauchet L; Kalamaridès M; Menei P; Deruty R; Moreau JJ; Fèvre-Montange M; Guyotat J
J Neurooncol; 2009 Dec; 95(3):367-375. PubMed ID: 19562258
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
[TBL] [Abstract][Full Text] [Related]
7. Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
Karsy M; Burnett B; Di Ieva A; Cusimano MD; Jensen RL
J Neurosurg; 2018 Mar; 128(3):657-666. PubMed ID: 28362240
[TBL] [Abstract][Full Text] [Related]
8. Surgical Treatment and Predictive Factors for Atypical Meningiomas: A Multicentric Experience.
Dobran M; Marini A; Splavski B; Rotim K; Liverotti V; Nasi D; Iacoangeli M
World Neurosurg; 2020 Dec; 144():e1-e8. PubMed ID: 32311549
[TBL] [Abstract][Full Text] [Related]
9. Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.
Ren L; Hua L; Bao Z; Deng J; Wang D; Chen J; Chen H; Juratli TA; Wakimoto H; Gong Y
J Neurooncol; 2023 Jan; 161(2):193-202. PubMed ID: 35612696
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants.
Alimohammadi E; Bagheri SR; Sadeghsalehi A; Rizevandi P; Rezaie Z; Abdi A
Acta Neurol Belg; 2020 Dec; 120(6):1341-1350. PubMed ID: 31222512
[TBL] [Abstract][Full Text] [Related]
11. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.
Gousias K; Schramm J; Simon M
J Neurosurg; 2016 Sep; 125(3):551-60. PubMed ID: 26824369
[TBL] [Abstract][Full Text] [Related]
12. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy for atypical meningiomas.
Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
[TBL] [Abstract][Full Text] [Related]
14. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Radiosurgery for Atypical (World Health Organization II) and Anaplastic (World Health Organization III) Meningiomas: Results From a Multicenter, International Cohort Study.
Shepard MJ; Xu Z; Kearns K; Li C; Chatrath A; Sheehan K; Sheehan D; Faramand A; Niranjan A; Kano H; Gurewitz J; Bernstein K; Liscak R; Guseynova K; Grills IS; Parzen JS; Cifarelli CP; Rehman AA; Atik A; Bakhsheshian J; Zada G; Chang E; Giannotta S; Speckter H; Wu HM; Kondziolka D; Golfinos JG; Mathieu D; Lee CC; Warnick RE; Lunsford LD; Sheehan JP
Neurosurgery; 2021 Apr; 88(5):980-988. PubMed ID: 33469655
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institution.
Balasubramanian SK; Sharma M; Silva D; Karivedu V; Schmitt P; Stevens GH; Barnett GH; Prayson RA; Elson P; Suh JH; Murphy ES; Chao ST
J Neurooncol; 2017 Feb; 131(3):555-563. PubMed ID: 27864703
[TBL] [Abstract][Full Text] [Related]
17. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ
J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286
[TBL] [Abstract][Full Text] [Related]
18. Treatment Response and Prognosis After Recurrence of Atypical Meningiomas.
Cao X; Hao S; Wu Z; Wang L; Jia G; Zhang L; Zhang J
World Neurosurg; 2015 Oct; 84(4):1014-9. PubMed ID: 26038336
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
[TBL] [Abstract][Full Text] [Related]
20. Low Transforming Growth Factor-β3 Expression Predicts Tumor Malignancy in Meningiomas.
Ma J; Li D; Chen Y; Zhang Y; Song L; Tian K; Yang Y; Chen L; Weng J; Cao X; Hao S; Wang L; Wu Z; Zhang J
World Neurosurg; 2019 May; 125():e353-e360. PubMed ID: 30703597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
